1. Home
  2. MOD vs IBRX Comparison

MOD vs IBRX Comparison

Compare MOD & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Modine Manufacturing Company

MOD

Modine Manufacturing Company

HOLD

Current Price

$136.76

Market Cap

9.5B

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$6.05

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOD
IBRX
Founded
1916
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
8.2B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
MOD
IBRX
Price
$136.76
$6.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
4
Target Price
★ $210.89
$14.25
AVG Volume (30 Days)
2.1M
★ 13.2M
Earning Date
11-03-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 38.71
EPS
★ 1.93
N/A
Revenue
★ $1,352,500,000.00
$113,288,000.00
Revenue This Year
N/A
$99.98
Revenue Next Year
$37.93
$108.29
P/E Ratio
$54.86
★ N/A
Revenue Growth
N/A
★ 668.31
52 Week Low
$87.84
$1.95
52 Week High
$323.25
$12.43

Technical Indicators

Market Signals
Indicator
MOD
IBRX
Relative Strength Index (RSI) 33.31 33.03
Support Level $87.84 $5.58
Resistance Level $198.53 $8.62
Average True Range (ATR) 8.52 0.61
MACD -0.51 -0.26
Stochastic Oscillator 31.64 2.20

Price Performance

Historical Comparison
MOD
IBRX

About MOD Modine Manufacturing Company

Modine Manufacturing Co provides thermal management solutions to diversified markets and customers. The company provides engineered heat transfer systems and heat transfer components for use in on- and off-highway original equipment manufacturer (OEM) vehicular applications in the United States. It offers powertrain cooling products, such as engine cooling assemblies, radiators, condensers, and charge air coolers; auxiliary cooling products, including power steering and transmission oil coolers. Its operating segments include Climate Solutions and Performance Technologies.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: